New Delhi: The SAMRIDH Healthcare Blended Finance Facilitysupported by the United States Agency for International Development (USAIDand implemented by IPE Globalhas supported Clensta with a capital inflow of Rs 1.5 crores (USD 1,88,529). The company’s objective behind this capital investment is to enhance access to affordable healthcare and hygienic products in healthcare facilities and other touchpoints in tier 2 and 3 regions and in vulnerable pockets of tier 1 cities.
While highlighting the importance of this new partnership, Himanshu SikkaProject Director, Samridhand Chief Strategy and Diversification Officer, IPE Global, said, “Through our partnership with Clensta, we aim to reduce the risk factor of patients in tier 2 and 3 cities by enabling healthcare facilities to access affordable waterless hygiene and medicated products. waterless technology can be a game changer in these locations where acute water shortages have been a long-standing challenge.”
according to the US Center for Disease Control and Prevention, nearly 1.7 million hospitalized patients annually acquire healthcare-associated infections (HCAIs) while being treated for other health issues. More than 98,000 of these patients (one in 17) die from HCAIs. These metrics are more pronounced in low-to-middle-income countries (LMICs), including India, with 1 in 10 patients infected in healthcare facilities. Furthermore, in the low-resource settings of tier 2 and 3 cities, the threat of contamination in hospitals is often compounded by acute water shortages.
Clensta, a Gurgaon-based start-up incubated at IIT Delhi, developed its waterless technology, which the company claims is novel and aims at the cleansing and disinfection of the entire body without water. Other technologies, such as Prolonged Antiviral Protection (PAP), developed by the company, claim to provide better protection against COVID and other microbial infections. These products aim to assist with the cleanliness and hygiene of bedridden individuals or patients in ICU care without water, making their application ideal for low-resource settings.
Speaking about the collaboration between Clensta and SAMRIDH, Puneet Gupta, Founder, Clensta, stated, “The purpose behind our healthcare portfolio: waterless and COVID protection products has always been a thoughtful one, to ensure we protect as many individuals as possible from the same challenges I have faced or seen people face in my journey. This collaboration will help us solve problems on a wider scale. The waterless portfolio will ensure that there are very low chances of hospital-acquired infections in vulnerable areas, thus taking us a step further to achieving a better world. The validation from supporting SAMRIDH also proves that our healthcare portfolio is truly innovative; this step is crucial as it will help us serve more and more people through other partnerships.”
The partnership with SAMRIDH Healthcare Blended Finance Facility, according to the company, will help Clensta to expand its sales force and strengthen the distribution channels to make its hygiene products available to over 2,100 nursing homes, clinics, pharmacies, hospitals, and other touchpoints such as direct purchases by central government agencies and PSUs, thereby reducing healthcare-acquired infections and democratizing the personal hygiene index across Tier 2 and Tier 3 cities in India.